Experimental Haematology (Professor Dr Dr Axel Schambach, Philippe Vollmer Barbosa), the MHH Clinic for Haematology, Haemostaseology, Oncology and Stem Cell Transplantation (Professor Dr Dr Adrian Schwarzer) [...] 2.5 million euros for the further development of new antiviral agents. The research team led by Professor Dr Dr Axel Schambach, Head of the Institute of Experimental Haematology at Hannover Medical School [...] paralyse different sections of the parainfluenza virus genome that the virus needs to replicate," says Professor Schambach. Effectiveness of RNAi candidates successfully tested in lung tissue RNAi technology uses

tion offensive in medicine," says Professor Kahl. The project is a cooperation between MHH, Leibniz Universität Hannover (Professor Dr Michael H. Breitner, Professor Dr Annika Herr, PD Dr Jan Zeidler) [...] available in Germany, they are only used by less than one percent of those affected. A study led by Professor Dr. Kai G. Kahl, Managing Senior Physician at the Department of Psychiatry, Social Psychiatry and [...] for those affected and for society due to illness-related unemployment or early retirement," says Professor Kahl. Only about a quarter of those with the disease take part in therapy at all. Among other things

to later stages of life,” explains Professor Dr. Siegfried Geyer, Head of Medical Sociology at Hannover Medical School (MHH). From this positive perspective, Professor Geyer and his working group investigated [...] the health status of different age groups in the population developed. Compression and expansion Professor Geyer and his team have been working on the topic of “compression and expansion of morbidity” since [...] at the period from 2005 to 2019 and compared cohorts of the same age at different times,” says Professor Geyer. The surprising result: the health status of the elderly, which used to improve over the years

Clinic for Radiotherapy and Special Oncology, headed by Professor Dr. Hans Christiansen, and the Clinic for Cardiology and Angiology, headed by Professor Dr. Johann Bauersachs, work closely together on this [...] significantly reduced. That is a huge gain for those affected," explains Professor Duncker. SERVICE: For more information , contact Professor Dr Roland Merten, Clinic for Radiotherapy and Special Oncology, merten [...] life-threatening cardiac arrhythmias despite the generally very good treatment options," explains Professor Dr. David Duncker, head of the Hannover Heart Rhythm Centre (HHC) at the Clinic for Cardiology and

underlying depression. Professor Frieling is convinced that patients will already benefit from the research results in the medium term. SERVICE: For further information , please contact Professor Dr Helge Frieling [...] what already works in oncology is also to become possible in psychiatry. Under the leadership of Professor Dr Helge Frieling, Vice Head of the Department of Psychiatry, Social Psychiatry and Psychotherapy [...] one in four to five patients. And besides, antidepressants often have strong side effects," says Professor Frieling, who is coordinating the P4D research project. Instead of trying out different treatment

time the age group over 60 has the highest consumption of blood products. A research team led by Professor Dr Rainer Blasczyk, head of the Institute for Transfusion Medicine and Transplant Engineering at [...] without antigens "In many regions of the world, blood reserves are already in short supply," says Professor Blasczyk. In addition, he says, it is not always easy to transport fresh blood to where it is currently [...] that does not carry AB0 antigens and is therefore equally suitable for all recipients," explains Professor Dr. Constanca Figueiredo, senior scientist at the Institute and deputy project leader. In addition

human resources management and the design of efficient administrative processes," said Professor Manns. "Professor Lammert, as the new Vice President for Patient Care, combines exactly the expertise we [...] available," he emphasized during a press briefing at MHH on April 22, 2021. According to MHH President Professor Dr. Michael Manns, the university has great potentials, each of which can also be developed very [...] t of the campus." "Lean management and short decision-making paths" for new building planning. Professor Manns is aware that the new presidium is under pressure to succeed. "Our employees are highly motivated

unknown, newly emerging virus types," Professor Schambach emphasises. The iGUARD project is a cooperation between the MHH Institute for Experimental Haematology (Professor Dr. Dr. Axel Schambach, Philippe Vollmer [...] Fraunhofer ITEM (Professor Dr. Armin Braun, Philippe Vollmer Barbosa). After one year, the team can apply for the third funding round. SERVICE: For further information , please contact Professor Dr. Dr. Axel [...] "iGUARD (integrated Guided Ultrafast Antiviral RNAi Drug development)", a research team led by Professor Dr. Axel Schambach, head of the Institute for Experimental Haematology at the Hannover Medical School

deficiency,” explains Professor Dr. Johann Bauersachs, Director of the Department of Cardiology and Angiology. Professor Bauersachs is leading the pilot study together with Professor Dr. Tibor Kempf, senior [...] patients with heart failure. “The current treatment guidelines only recommend infusions,” says Professor Kempf. In the pilot study ORION-HF, cardiologists are now testing an iron preparation that has already [...] therapy with the tablets leads to an increase in haemoglobin and iron levels in the blood,” explains Professor Kempf. For the patients, this would mean that they would be better supplied with oxygen and suffer

years of work, this commission has made up-to-date recommendations on how COPD can be reduced. Professor Dr. Tobias Welte, Director of the Department of Pneumology at the Hannover Medical School (MHH) [...] diseases such as asthma, there has been no breakthrough in the treatment of COPD for decades," says Professor Welte. "We are, so to speak, at the therapeutic standard of the 1960s." According to the lung expert [...] insufficient because it does not reliably detect early signs of changes in the airways," emphasises Professor Welte. In general, the diagnosis is made much too late. "The individual courses of the disease vary